Titanium induced production of chemokines CCL17/TARC and CCL22/MDC in human osteoclasts and osteoblasts

Journal of Biomedical Materials Research - Part A

Volumn 92, Issue 2, 2010, Pages 475-483

  Cadosch, Dieter ^a,b   Gautschi, Oliver P ^a,b   Chan, Erwin ^a   Simmen, Hans Peter ^c   Filgueira, Luis ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b ROYAL PERTH HOSPITAL   (Australia)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

CCL17; CCL22; Osteoblast; Osteoclast; Titanium

Indexed keywords

ASEPTIC LOOSENING; BONE-IMPLANT INTERFACES; CCL17; CCL22; CHEMOKINES; CYTOKINES; ELISA ASSAY; INFLAMMATORY CYTOKINES; ORTHOPEDIC IMPLANT; OSTEOCLAST DIFFERENTIATION; OSTEOCLAST PRECURSOR; OSTEOCLASTOGENESIS; PROINFLAMMATORY CYTOKINES; QUANTITATIVE REAL TIME PCR; UPREGULATED EXPRESSION;

FLOW CYTOMETRY; OSTEOBLASTS; PEPTIDES;

TITANIUM;

CHEMOKINE; CHEMOKINE RECEPTOR CCR4; COLONY STIMULATING FACTOR 1; OSTEOCLAST DIFFERENTIATION FACTOR; THYMUS AND ACTIVATION REGULATED CHEMOKINE; TITANIUM;

ARTICLE; CELL ACTIVITY; CELL DIFFERENTIATION; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMPLANT; INCUBATION TIME; OSTEOBLAST; OSTEOCLAST; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION;

CHEMOKINE CCL17; CHEMOKINE CCL22; CORROSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMANS; MACROPHAGE COLONY-STIMULATING FACTOR; OSTEOBLASTS; OSTEOCLASTS; PROSTHESES AND IMPLANTS; RANK LIGAND; RECEPTORS, CCR4; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TITANIUM;

EID: 75149134683     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.32390     Document Type: Article

References (38)

1. Harris WH. Osteolysis and particle disease in hip replacement. A review. Acta Orthop Scand 1994;65:113-123.
2. Bauer TW. Particles and periimplant bone resorption. Clin Orthop Relat Res 2002;405:138-143.
3. Fanti P, Kindy MS, Mohapatra S, Klein J, Colombo G, Malluche HH. Dose-dependent effects of aluminum on osteocalcin synthesis in osteoblast-like ROS 17/2 cells in culture. Am J Physiol 1992;263:E1113-E1118.
4. Granchi D, Amato I, Battistelli L, Ciapetti G, Pagani S, Avnet S, Baldini N, Giunti A. Molecular basis of osteoclastogenesis induced by osteoblasts exposed to wear particles. Biomaterials 2005;26:2371-2379.
5. Matthews JB, Green TR, Stone MH, Wroblewski BM, Fisher J, Ingham E. Comparison of the response of three human monocytic cell lines to challenge with polyethylene particles of known size and dose. J Mater Sci Mater Med 2001;12:249-258.
6. Thompson GJ, Puleo DA. Effects of sublethal metal ion concentrations on osteogenic cells derived from bone marrow stromal cells. J Appl Biomater 1995;6:249-258.
7. Ragab AA, Nalepka JL, Bi Y, Greenfield EM. Cytokines synergistically induce osteoclast differentiation: Support by immortalized or normal calvarial cells. Am J Physiol Cell Physiol 2002;283:C679-C687.
8. Tengvall P, Lundstrom I. Physico-chemical considerations of titanium as a biomaterial. Clin Mater 1992;9:115-134.
9. Okazaki Y, Gotoh E, Manabe T, Kobayashi K. Comparison of metal concentrations in rat tibia tissues with various metallic implants. Biomaterials 2004;25:5913-5920.
10. Savarino L, Granchi D, Ciapetti G, Cenni E, Nardi Pantoli A, Rotini R, Veronesi CA, Baldini N, Giunti A. Ion release in patients with metal-on-metal hip bearings in total joint replacement: A comparison with metal-on-polyethylene bearings. J Biomed Mater Res 2002;63:467-474.
11. Urban RM, Jacobs JJ, Tomlinson MJ, Gavrilovic J, Black J, Peoc'h M. Dissemination of wear particles to the liver, spleen, and abdominal lymph nodes of patients with hip or knee replacement. J Bone Joint Surg Am 2000;82:457-476.
12. Dorr LD, Bloebaum R, Emmanual J, Meldrum R. Histologic, biochemical, and ion analysis of tissue and fluids retrieved during total hip arthroplasty. Clin Orthop Relat Res 1990;261:82-95.
13. Jacobs JJ, Skipor AK, Patterson LM, Hallab NJ, Paprosky WG, Black J, Galante JO. Metal release in patients who have had a primary total hip arthroplasty. A prospective, controlled, longitudinal study. J Bone Joint Surg Am 1998;80:1447-1458.
14. Cadosch D, Chan E, Gautschi OP, Meagher J, Zellweger R, Filgueira L. Titanium IV ions induced human osteoclast differentiation and enhanced bone resorption in vitro. J Biomed Mater Res A 2009;91:29-36.
15. Yoshie O, Imai T, Nomiyama H. Novel lymphocyte-specific CC chemokines and their receptors. J Leukoc Biol 1997;62: 634-644.
16. Radstake TR, van der Voort R, ten Brummelhuis M, de Waal Malefijt M, Looman M, Figdor CG, van den Berg WB, Barrera P, Adema GJ. Increased expression of CCL18, CCL19, and CCL17 by dendritic cells from patients with rheumatoid arthritis, and regulation by Fc γ receptors. Ann Rheum Dis 2005;64:359-367.
17. Meagher J, Zellweger R, Filgueira L. Functional dissociation of the basolateral transcytotic compartment from the apical phago-lysosomal compartment in human osteoclasts. J Histochem Cytochem 2005;53:665-670.
18. Greenfield EM, Bi Y, Ragab AA, Goldberg VM, Van De Motter RR. The role of osteoclast differentiation in aseptic loosening. J Orthop Res 2002;20:1-8.
19. Bi Y, Van De Motter RR, Ragab AA, Goldberg VM, Anderson JM, Greenfield EM. Titanium particles stimulate bone resorption by inducing differentiation of murine osteoclasts. J Bone Joint Surg Am 2001;83:501-508.
20. Sommer B, Felix R, Sprecher C, Leunig M, Ganz R, Hofstetter W. Wear particles and surface topographies are modulators of osteoclastogenesis in vitro. J Biomed Mater Res A 2005; 72:67-76.
21. Jiranek WA, Machado M, Jasty M, Jevsevar D, Wolfe HJ, Goldring SR, Goldberg MJ, Harris WH. Production of cytokines around loosened cemented acetabular components. Analysis with immunohistochemical techniques and in situ hybridization. J Bone Joint Surg Am 1993;75:863-879.
22. Kim KJ, Rubash HE, Wilson SC, D'Antonio JA, McClain EJ. A histologic and biochemical comparison of the interface tissues in cementless and cemented hip prostheses. Clin Orthop Relat Res 1993;287:142-152.
23. Stea S, Visentin M, Granchi D, Ciapetti G, Donati ME, Sudanese A, Zanotti C, Toni A. Cytokines and osteolysis around total hip prostheses. Cytokine 2000;12:1575-1579.
24. Lean JM, Murphy C, Fuller K, Chambers TJ. CCL9/MIP-1gamma and its receptor CCR1 are the major chemokine ligand/receptor species expressed by osteoclasts. J Cell Biochem 2002;87:386-393.
25. Nakamura ES, Koizumi K, Kobayashi M, Saitoh Y, Arita Y, Nakayama T, Sakurai H, Yoshie O, Saiki I. RANKL-induced CCL22/macrophage-derived chemokine produced from osteoclasts potentially promotes the bone metastasis of lung cancer expressing its receptor CCR4. Clin Exp Metastasis 2006;23:9-18.
26. Ferenczi K, Fuhlbrigge RC, Pinkus J, Pinkus GS, Kupper TS. Increased CCR4 expression in cutaneous T cell lymphoma. J Invest Dermatol 2002;119:1405-1410.
27. Campbell JJ, Butcher EC. Chemokines in tissue-specific and microenvironment-specific lymphocyte homing. Curr Opin Immunol 2000;12:336-341.
28. Rossi D, Zlotnik A. The biology of chemokines and their receptors. Annu Rev Immunol 2000;18:217-242.
29. Zlotnik A, Yoshie O. Chemokines: A new classification system and their role in immunity. Immunity 2000;12:121-127.
30. Acosta-Rodriguez EV, Rivino L, Geginat J, Jarrossay D, Gattorno M, Lanzavecchia A, Sallusto F, Napolitani G. Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat Immunol 2007;8:639-646.
31. Baatar D, Olkhanud P, Sumitomo K, Taub D, Gress R, Biragyn A. Human peripheral blood T regulatory cells (Tregs), functionally primed CCR4+ Tregs and unprimed CCR4-Tregs, regulate effector T cells using FasL. J Immunol 2007; 178:4891-4900.
32. Wooley PH, Nasser S, Fitzgerald RH. The immune response to implant materials in humans. Clin Orthop Relat Res 1996; 326:63-70.
33. Schmidt-Weber CB, Akdis M, Akdis CA. TH17 cells in the big picture of immunology. J Allergy Clin Immunol 2007;120: 247-254.
34. Goldring SR, Schiller AL, Roelke M, Rourke CM, O'Neil DA, Harris WH. The synovial-like membrane at the bone-cement interface in loose total hip replacements and its proposed role in bone lysis. J Bone Joint Surg Am 1983;65:575-584.
35. Sato K, Suematsu A, Okamoto K, Yamaguchi A, Morishita Y, Kadono Y, Tanaka S, Kodama T, Akira S, Iwakura Y, Cua DJ, Takayanagi H. Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. J Exp Med 2006;203:2673-2682.
36. Bachmann MF, Wong BR, Josien R, Steinman RM, Oxenius A, Choi Y. TRANCE, a tumor necrosis factor family member critical for CD40 ligand-independent T helper cell activation. J Exp Med 1999;189:1025-1031.
37. Fouque-Aubert A, Chapurlat R. Influence of RANKL inhibition on immune system in the treatment of bone diseases. Joint Bone Spine 2008;75:5-10.
38. Kawai T, Matsuyama T, Hosokawa Y, Makihira S, Seki M, Karimbux NY, Goncalves RB, Valverde P, Dibart S, Li YP, Miranda LA, Ernst CW, Izumi Y, Taubman MA. B and T lymphocytes are the primary sources of RANKL in the bone resorptive lesion of periodontal disease. Am J Pathol 2006;169:987-998.